Intravitreal triamcinolone acetonide injection 4 mg vs sham
Visual acuity · macular edema in diabetes
1 finding from 1 review
- no estimate extractedStudies not reportedLow
Findings
What do systematic reviews say?
18 questions · 18 findings · 1 reviews
No studies found 4 · 22.2%GRADE not reported 0 · 0%Very low 5 · 27.8%Low 7 · 38.9%Moderate 2 · 11.1%High 0 · 0%
Intravitreal triamcinolone acetonide injection 4 mg vs sham
Gain of 3 or more lines of visual acuity · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes gain of three or more lines visual acuity ‐ 24 months** compared with sham (very low certainty).
1 finding from 1 review
- RR 4.12 [0.48, 34.99]Studies not reportedVery low
Intravitreal triamcinolone acetonide injection 4 mg vs sham
Change in retinal thickness (micron) (negative is better) · macular edema in diabetes
1 finding from 1 review
- no estimate extractedStudies not reportedLow
Intravitreal triamcinolone acetonide injection 4 mg vs sham
Cataract progression ‐ 24 months · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg showed no clear difference in cataract progression ‐ 24 months compared with sham (low certainty).
1 finding from 1 review
- RR 3 [0.97, 9.3]Studies not reportedLow
Intravitreal triamcinolone acetonide injection 4 mg vs sham
Use of IOP‐lowering medications ‐ 24 months · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes use of IOP‐lowering medications ‐ 24 months compared with sham (very low certainty).
1 finding from 1 review
- RR 21.6 [1.32, 354.7]Studies not reportedVery low
Intravitreal triamcinolone acetonide injection 4 mg vs sham
Surgery for glaucoma ‐ 24 months · macular edema in diabetes
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intravitreal triamcinolone acetonide injection 4 mg vs macular laser
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes change in visual acuity (logMAR) ‐ 12 months (negative is better) compared with macular laser (very low certainty).
1 finding from 1 review
- MD 0.02Studies not reportedVery low
Intravitreal triamcinolone acetonide injection 4 mg vs macular laser
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg showed no clear difference in gain of three or more lines visual acuity ‐ 12 months compared with macular laser (low certainty).
1 finding from 1 review
- RR 0.85 [0.55, 1.3]Studies not reportedLow
Intravitreal triamcinolone acetonide injection 4 mg vs macular laser
Change in retinal thickness (micron) (negative is better) · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes change in retinal thickness (micron) (negative is better) compared with macular laser (very low certainty).
1 finding from 1 review
- MD 5Studies not reportedVery low
Intravitreal triamcinolone acetonide injection 4 mg vs macular laser
Cataract progression · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg probably leads to higher cataract progression ‐ 9 to 24 months compared with macular laser (moderate certainty).
1 finding from 1 review
- RR 2.68 [2.21, 3.24]Studies not reportedModerate
Intravitreal triamcinolone acetonide injection 4 mg vs macular laser
Use of IOP‐lowering medications · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg probably leads to higher use of IOP‐lowering medications ‐ 9 to 24 months compared with macular laser (moderate certainty).
1 finding from 1 review
- RR 3.92 [2.59, 5.96]Studies not reportedModerate
Intravitreal triamcinolone acetonide injection 4 mg vs macular laser
Surgery for glaucoma ‐ 24 months · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg showed no clear difference in surgery for glaucoma ‐ 9 to 24 months compared with macular laser (low certainty).
1 finding from 1 review
- RR 11.68 [0.63, 216]Studies not reportedLow
Intravitreal triamcinolone acetonide injection 4 mg vs antiVEGF
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · macular edema in diabetes
1 finding from 1 review
- no estimate extracted1 study · 30 participantsLow
Intravitreal triamcinolone acetonide injection 4 mg vs antiVEGF
Gain of 3 or more lines of visual acuity · macular edema in diabetes
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intravitreal triamcinolone acetonide injection 4 mg vs antiVEGF
Central retinal thickness μm (CRT) change at 1 year The aim of treatment is to reduce central retinal thickness so thinner is better. · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes change in central retinal thickness (micron) ‐ 12 months (negative… compared with antiVEGF (very low certainty).
1 finding from 1 review
- no estimate extracted1 study · 30 participantsVery low
Intravitreal triamcinolone acetonide injection 4 mg vs antiVEGF
Cataract progression · macular edema in diabetes
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intravitreal triamcinolone acetonide injection 4 mg vs antiVEGF
Use of IOP‐lowering medications · macular edema in diabetes
1 finding from 1 review
- no estimate extractedStudies not reportedLow
Intravitreal triamcinolone acetonide injection 4 mg vs antiVEGF
Surgery for glaucoma · macular edema in diabetes
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found